Molecular Characterization of a Novel Mucopolysaccharidosis (MPS) type VI-causing Mutation – Indirect Proof of Principle on its Pathogenicity
Introduction: With its unprecedented throughput, scalability and speed, next-generation sequencing (NGS) is revolutionizing clinical research. Targeted sequencing in particular is now available in many labs. Still, whenever a novel variant is detected, its pathogenicity must be carefully assessed an...
Main Author: | |
---|---|
Other Authors: | , , |
Format: | conferenceObject |
Language: | eng |
Published: |
2019
|
Subjects: | |
Online Access: | http://hdl.handle.net/10400.18/6289 |
Country: | Portugal |
Oai: | oai:repositorio.insa.pt:10400.18/6289 |